Amana Nasir
Pediatric Gastroenterology · Saint Louis, MONPI 1306050273
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $91,249 of the $110,529 with a category attached, or 82.6%. 29 manufacturers reported payments, led by Sanofi at 56.2% of the total. Among pediatric gastroenterology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $379.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$62K
- Regeneron Healthcare Solutions, Inc.$29K
- QOL Medical, LLC$17K
- Mirum Pharmaceuticals, Inc.$372
- Takeda Pharmaceuticals U.S.A., Inc.$315
- E.r. Squibb & Sons, L.L.C.$304
- plus $2K from 23 others
What the payments were for
- Consulting fees$7,6447%
- Speaking & faculty fees$91,24983%
- Travel & lodging$4,8404%
- Food & beverage$6,7646%
- Education$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 77 | $62,141 |
| Regeneron Healthcare Solutions, Inc. | 43 | $28,573 |
| QOL Medical, LLC | 38 | $16,785 |
| Mirum Pharmaceuticals, Inc. | 18 | $372 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $315 |
| E.r. Squibb & Sons, L.L.C. | 6 | $304 |
| Ipsen Biopharmaceuticals, Inc | 7 | $303 |
| Nestle Healthcare Nutrition Inc. | 12 | $214 |
| Novartis | 11 | $190 |
| AbbVie | 11 | $170 |
| Sandoz | 8 | $139 |
| Shockwave Medical, Inc | 1 | $136 |
| Ironwood Pharmaceuticals, Inc | 5 | $108 |
| GSK | 7 | $104 |
| Travere Therapeutics, Inc. | 7 | $101 |
| Gilead | 1 | $92 |
| Capsovision, Inc. | 4 | $66 |
| AstraZeneca | 4 | $63 |
| Fresenius Kabi USA, LLC | 3 | $59 |
| Evoendo, Inc | 1 | $51 |
| Neuraxis, Inc. | 1 | $48 |
| Amgen | 2 | $39 |
| Albireo Pharma, Inc. | 2 | $38 |
| Intrabio Inc | 1 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$80,137
- Sucraid$16,362
- Bylvay$150
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$136
How this compares
$110,529 in reported general payments places this provider in the 95th percentile of 60 pediatric gastroenterology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $95,168 |
Paid to pharmacies, not to this prescriber.
Other pediatric gastroenterology in Saint Louis
- Jeffrey TeckmanSaint Louis$59K
- Ajay JainSaint Louis$57K
- Janis StollSaint Louis$14K
- Jose DerdoySaint Louis$6K
- Fernando Medina CarbonellSaint Louis$3K
- Karine AmirikianSaint Louis$1K
- Aniruddh SetyaSaint Louis$1K
- Sarah HenkelSaint Louis$746
- Jerome MollestonSaint Louis$220
- Ryan PitmanSaint Louis$195
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.